First, in 2001, CRI formed a partnership with the Ludwig Institute for Cancer Research to develop the Cancer Vaccine Collaborative (CVC)-- a centralized, academic, global network of clinical trial sites,
immune monitoring laboratories, and clinic - grade, GMP cancer vaccine production facilities.
They are seeking a Scientific Officer 2 to jointly work within our Tissue Biomarkers Team and Tumour Immunology and Inflammation
Monitoring Laboratory Team (TIIML) to assist in the development and implementation of tissue biomarkers to
monitor immune status and responses.